Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing
- 24 September 2008
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 1 (6) , 489-496
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Biomedical applications of sheep models: from asthma to vaccinesTrends in Biotechnology, 2008
- Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary diseaseVaccine, 2006
- Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines: Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005Vaccine, 2006
- Inhalative vaccination with pneumococcal polysaccharide in healthy volunteersVaccine, 2005
- Anatomical localisation and histology of the ovine tonsilsVeterinary Immunology and Immunopathology, 2005
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasiaVaccine, 2004
- Influenza Vaccination Levels and Influenza-Like Illness in Long-Term-Care Facilities for Elderly People in Niigata, Japan, During an Influenza A (H3N2) EpidemicInfection Control & Hospital Epidemiology, 2000
- Influenza VaccinesDrugs, 1997
- Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine1969